Study Stopped
Modification of the device
Automated Postoperative Sedation After Cardiac Surgery
SEPOCA
Postoperative Sedation After Cardiac Surgery : Comparison Between Manual Administration and Automated Sedation
1 other identifier
interventional
7
1 country
1
Brief Summary
This study compares automated administration of propofol and remifentanil guided by the Bispectral index (BIS) versus manual administration for sedation after cardiac surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 19, 2018
CompletedFirst Posted
Study publicly available on registry
May 7, 2018
CompletedStudy Start
First participant enrolled
December 17, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 28, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2019
CompletedNovember 5, 2021
October 1, 2021
3 months
April 19, 2018
October 28, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Adequate sedation
Percentage of time with BIS between 55 and 75 (BIS(55-75))
6 hours
Secondary Outcomes (14)
Period of too deep sedation
6 hours
Period of too light sedation
6 hours
Incidence of Burst Suppression (bsr) during sedation
6 hours
Level of sedation
6 hours
Level of pain during sedation
6 hours
- +9 more secondary outcomes
Study Arms (2)
Automated postoperative sedation
EXPERIMENTALAutomated administration of Propofol and Remifentanil.
Manual postoperative sedation
ACTIVE COMPARATORManual administration of Propofol and Remifentanil.
Interventions
The dosage is modified automatically by the device or according to the new medical prescription.
The dosage is modified automatically by the device or according to the new medical prescription.
Propofol and Remifentanil are administered automatically using a closed-loop system. Bispectral index is used as the input signal and an algorithm defines the appropriate concentrations of propofol and remifentanil. Adequate postoperative sedation is defined by a bispectral index between 55 and 75.
Eligibility Criteria
You may qualify if:
- Cardiac surgical procedure requiring postoperative sedation
- Low operative risk : EuroSCORE 2 ≤ 5%
- Consent for participation
- Affiliation to the social security system
You may not qualify if:
- Pregnant or breastfeeding women
- Neurological or muscular disorder
- Pacemaker
- Hypersensitivity to propofol or remifentanil
- Communication difficulties or neuropsychiatric disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CMC Ambroise Paré
Neuilly-sur-Seine, Île-de-France Region, 92200, France
Related Publications (2)
Liu N, Chazot T, Hamada S, Landais A, Boichut N, Dussaussoy C, Trillat B, Beydon L, Samain E, Sessler DI, Fischler M. Closed-loop coadministration of propofol and remifentanil guided by bispectral index: a randomized multicenter study. Anesth Analg. 2011 Mar;112(3):546-57. doi: 10.1213/ANE.0b013e318205680b. Epub 2011 Jan 13.
PMID: 21233500RESULTLe Guen M, Liu N, Bourgeois E, Chazot T, Sessler DI, Rouby JJ, Fischler M. Automated sedation outperforms manual administration of propofol and remifentanil in critically ill patients with deep sedation: a randomized phase II trial. Intensive Care Med. 2013 Mar;39(3):454-62. doi: 10.1007/s00134-012-2762-2. Epub 2012 Dec 6.
PMID: 23223772RESULT
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Thierry Chazot, MD
Hôpital FOCH
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 19, 2018
First Posted
May 7, 2018
Study Start
December 17, 2018
Primary Completion
March 28, 2019
Study Completion
March 30, 2019
Last Updated
November 5, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will not share